Wellnex Life Limited (AIM:WNX)

London · Delayed Price · Currency is GBP · Price in GBX

3.250

-1.000 (-23.53%)

Jun 16, 2026, 4:10 PM GMT

-79.03% (1Y)

Market Cap	1.73M -79.4%
Revenue (ttm)	12.18M +6.3%
Net Income	-4.89M
EPS	-0.10
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	129,628
Open	3.500
Previous Close	4.250
Day's Range	3.250 - 3.500
52-Week Range	3.250 - 15.500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Wellnex Life

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life bran... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2011

Country Australia

Stock Exchange London Stock Exchange AIM

Ticker Symbol WNX

Financial Performance

In fiscal year 2025, Wellnex Life's revenue was 23.63 million, an increase of 40.39% compared to the previous year's 16.83 million. Losses were -15.60 million, 13.6% more than in 2024.

Financial numbers in AUD Financial Statements